Trial NCT04781647

View at ClinicalTrials.gov 
Org. Study IDs: ABI-H0731-203

Last trial update was posted on 2023-10-06

MeSH Interventions

Entecavir Interferon-alpha Interferons

MeSH Conditions

Hepatitis Hepatitis A Hepatitis B Hepatitis B, Chronic Hepatitis, Chronic

Other Conditions

Chronic Hepatitis B

Stopping Reasons

Study ABI-H0731-203 was terminated early by the study Sponsor for strategic reasons to prioritize research and development efforts on finite and curative HBV therapies.

Limitations And Caveats

Study ABI-H0731-203 was terminated early by the study Sponsor for strategic reasons to prioritize research and development efforts on finite and curative HBV therapies. As a result, not all subjects completed Week 48 and some outcome measures were impacted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID